Any stock, in context
WINDLAS · Healthcare
Windlas Biotech Limited
Observation · 15 Oct 2026
How these are readWindlas Biotech closed at ₹923.5 on 15 Oct 2026, 7.6% above its 200-day average and 9.4% below its 50-day average: above the long line, below the short one. It sits 20.0% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it rose 9.4%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +7.6%
- the long line
- vs 50-day
- −9.4%
- the short line
- From 52w high
- −20.0%
- ₹697.4₹1,181.9
- 3 months
- +9.4%
- sector median −2.7% · 41 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹7.45 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +0.68%
- 1W
- –
- 1M
- −15.90%
- 3M
- +9.39%
- YTD
- –
- 1Y
- +1.91%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.